Africa And Asia Avian Flu Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2024 –2031 |
 시장 규모(기준 연도) |
USD 431.40 Million |
 시장 규모(예측 연도) |
USD 778.58 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
Asia Avian Flu Market Segmentation, By Strain (H5 Strain, H7 Strain, and H9 Strain), Type (Low Pathogenic Avian Influenza (LPAI) and Highly Pathogenic Avian Influenza (HPAI)), Vaccine (Gallimune/ Gallivac/ Volvac, Nobilis influenza h5n2, Mefluvac, Viraflu and Others), Vaccine Category (Inactivated Vaccines, Live Recombinant Vaccines, Combination Vaccines, and DNA vaccine), Application (Veterinary and Human), End User (Poultry Farms, Veterinary Clinics, Governmental Organizations, Research Institutes, and Others), Distribution Channel (Direct Tenders, Third Party Distributor, and Retail Sales) – Industry Trends and Forecast to 2031
Africa and Asia Avian Flu Market Analysis
The Africa and Asia Avian Flu market is influenced by various factors, including the recurrent outbreaks of avian influenza in poultry, zoonotic transmission potential, government response measures, and the rising focus on developing vaccines and antiviral drugs. In addition, the avian flu market is also driven by the rising frequency of avian influenza outbreaks and their economic impact on the poultry industry. Increasing government initiatives for disease surveillance and vaccine development further propel market growth.
Africa and Asia Avian Flu Market Size
Africa and Asia avian flu market size was valued at USD 431.40 million in 2023 and is projected to reach USD 778.58 million by 2031, with a CAGR of 7.8% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
Africa and Asia Avian Flu Market Trends
“Government Initiatives and Vaccination Programs”
One notable trend in Africa and Asia avian flu market is the increasing government initiatives and vaccination programs. Governments in Africa and Asia are increasingly recognizing the threat posed by highly pathogenic avian influenza (HPAI) and are taking proactive steps to mitigate its spread. Initiatives include the implementation of comprehensive vaccination programs aimed at poultry populations, which are critical in controlling outbreaks. These programs are often accompanied by awareness campaigns to educate farmers and the general public about the risks associated with avian influenza, proper biosecurity measures, and the importance of vaccination.
Such government-led efforts aim to safeguard public health but also protect the poultry industry, which is a significant contributor to the economy in these regions. By enhancing vaccination coverage and fostering awareness, authorities can reduce the incidence of HPAI, thus minimizing the economic losses associated with disease outbreaks. These initiatives often involve collaboration with international organizations and veterinary experts, ensuring that the programs are well-structured and effective.
For instance, in July 2024, according to an article published by FAO, the Food and Agriculture Organization (FAO) is urging immediate regional collaboration to address the increasing avian influenza cases in the Asia-Pacific region. This call to action comes after a meeting of regional experts in Bangkok, supported by USAID and the CDC. Hence, government initiatives and vaccination programs act as the trend for Africa and Asia avian flu market.
Report Scope Africa and Asia Avian Flu Market Segmentation
|
Attributes |
Africa and Africa and Asia Avian Flu Market Insights |
|
Segments Covered |
|
|
Countries Covered |
Afghanistan, Bangladesh, Bhutan, Brunei Darussalam, Cambodia, China, India, Indonesia, Japan, Kazakhstan, Kyrgyzstan, Laos, Malaysia, Maldives, Mongolia, Myanmar, Nepal, North Korea, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Tajikistan, Thailand, Timor-leste, Turkmenistan, Uzbekistan, Vietnam, Rest of Asia, Egypt, Nigeria, Kenya, Algeria, Ethiopia, Morocco, Ghana, Democratic Republic of Congo, Cameroon, Angola, Côte d'Ivoire, Libya, Rwanda, Burkina Faso, Mali, Benin, Namibia, Chad, Mauritius, Madagascar, Liberia, Congo (Rep), Guinea, Botswana, Eswatini, Niger, Malawi, Mozambique, Mauritania, Gabon, Eritrea, Gambia, Lesotho, Comoros, Burundi, Guinea-Bissau, Central African Republic, Cabo Verde, Djibouti, Equatorial Guinea, São Tomé and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, Togo, Tunisia, Uganda, Western Sahara, Zambia, Zimbabwe |
|
Key Market Players |
Boehringer Ingelheim International GmbH (Germany), Kemin Industries, Inc. (U.S.), Ceva (France), Merck & Co., Inc. (U.S.), China Animal Husbandry Group (China), Sinergium Biotech (Argentina), Qilu Animal Health Products Co., Ltd. (China) among others. |
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
Africa and Asia Avian Flu Market Definition
Avian influenza, commonly known as avian flu, is an infectious viral disease primarily affecting birds, particularly domestic poultry such as chickens and ducks. It is caused by influenza viruses of the family Orthomyxoviridae, with various strains, some of which can be highly pathogenic and result in severe illness and death among infected birds. Human infections with avian flu can occur, often through direct contact with infected birds or contaminated environments, leading to respiratory illness and, in some cases, severe complications. The disease poses a significant threat to the poultry industry and public health, necessitating ongoing surveillance and control measures.
Africa and Asia Avian Flu Market Dynamics
Drivers
- Rising Incidence of Avian Flu Outbreaks
The rising incidence of avian flu outbreaks in Africa and Asia has significantly heightened the demand for vaccines and treatments aimed at controlling and preventing the spread of the disease. The H5, H7, and H9 strains of avian influenza are particularly prevalent in these regions, leading to widespread concern among poultry farmers, governments, and public health officials. These outbreaks threaten the health of poultry populations and have implications for food security, public health, and economic stability.
For instance, in September 2024, the World Health Organization (WHO) was informed by Cambodia's International Health Regulations (IHR) National Focal Point about a confirmed case of avian influenza A(H5N1) in a 15-year-old child. This case is part of a total of 10 human infections reported in Cambodia in 2024. Since 2003, Cambodia has recorded 72 cases of human A(H5N1) infection, resulting in 43 deaths, with a Case Fatality Ratio (CFR) of 59.7%. According to the IHR (2005), any human infection with a novel influenza A virus subtype poses a significant public health risk and must be reported to the WHO.
Considering the escalating outbreaks, there is a heightened focus on creating and distributing effective vaccines and treatments. Governments and veterinary authorities are prioritizing vaccination programs to combat the risks associated with avian influenza. This increased commitment to disease prevention drives significant investments in research and development, leading to innovations in vaccine technology and production techniques.
- Growth of Poultry Farming Industry
The poultry farming industry in Africa and Asia is rapidly expanding due to rising consumer demand for poultry products and improved production capabilities. As more farms emerge and existing operations scale up, the density of poultry populations increases, creating a higher risk of avian flu outbreaks. This growing risk necessitates robust biosecurity measures and vaccination programs to protect both poultry and human populations from potential infections.
For instance, in May 2024, according to an article published by POULTRY WORLD, in Asia, consumer preferences are shifting toward poultry, which currently accounts for 25% of total animal protein consumption, while seafood constitutes 50% and other animal proteins make up the remaining 25%. This trend indicates a gradual increase in poultry demand. The growth in poultry consumption supports the expansion of the poultry farming industry, driving the need for enhanced biosecurity measures and vaccination programs in the African and Asian avian flu market.
Consequently, the expansion of poultry farming directly correlates with a heightened demand for avian flu vaccines, diagnostics, and biosecurity solutions. Farmers are more inclined to invest in preventive measures to safeguard their livestock and ensure the stability of their operations, while governments and veterinary authorities are likely to support these initiatives to avert outbreaks that could lead to significant economic and health consequences.
Opportunities
- Rising Investments in Poultry Industry
Rising investments in the poultry industry are being fueled by the increasing demand for poultry products in Africa and Asia. As consumers seek protein-rich diets, the sector is modernizing to efficiently meet this demand. This modernization includes adopting advanced farming techniques, enhancing biosecurity measures, and improving overall production capacity. Emphasizing biosecurity is critical, as it helps prevent the introduction and spread of avian influenza among flocks. With better biosecurity practices, poultry farmers are more likely to recognize the importance of vaccination in maintaining flock health and preventing disease outbreaks.
For Instance, in May 2024, according to an article published by WATTPoultry, investors are increasingly optimistic about the poultry industry in South and Southeast Asia, viewing it as a top investment opportunity. It is projected that 55% of global poultry growth will occur in Asia, with 14% attributed to South Asia and another 14% to Southeast Asia, according to data from the USDA and FAO. This anticipated growth in the poultry sector highlights rising investments, creating opportunities for the African and Asian avian flu market as demand for biosecurity measures and vaccination programs increases.
Moreover, increased investment also leads to improved veterinary care services, which are essential for the early detection and management of avian flu. As poultry operations modernize, integrating veterinary services with biosecurity protocols becomes vital. Farmers who invest in better practices are more inclined to utilize vaccines and veterinary care, thereby enhancing the demand for avian flu vaccines and treatments.
- Expansion of Vaccine Portfolios
The expansion of vaccine portfolios through the introduction of innovative vaccines, such as DNA and live recombinant vaccines, presents significant opportunities for companies operating in the avian flu market. These advanced vaccine technologies offer several advantages, including improved efficacy, faster production times, and enhanced safety profiles. For instance, DNA vaccines can be designed to target multiple strains of the avian flu virus, providing broader protection compared to traditional vaccines. Additionally, live recombinant vaccines, which incorporate genes from the avian flu virus into a harmless vector, can elicit strong immune responses, potentially leading to better disease control in poultry.
For instance,
- In April 2024, according to an article published by CureVac SE, CureVac SE has initiated a Phase 1/2 study of its investigational influenza A (H5N1) pre-pandemic vaccine, developed in collaboration with GSK. The H5N1 virus is a potential pandemic threat, occasionally transmitting from birds to humans. This monovalent vaccine uses CureVac’s second-generation mRNA technology to target the H5-antigen. This expansion of vaccine portfolios presents a key opportunity for the African and Asian Avian Flu markets by advancing vaccine options and strengthening preparedness against potential outbreaks
As the demand for effective vaccination programs grows, particularly in regions such as Africa and Asia, these new vaccine offerings can address unmet needs in both veterinary and human health sectors. The increasing incidence of avian flu outbreaks underscores the necessity for advanced vaccination solutions that can mitigate risks not only to poultry but also to public health. Companies that invest in research and development to create these innovative vaccines can gain a competitive edge, catering to the evolving needs of poultry farmers and public health authorities.
Restraints/Challenges
- High Cost of Vaccines and Treatments
The high cost of advanced vaccines and treatments for avian influenza presents a significant barrier to access, particularly in low- and middle-income countries across Africa and Asia. These regions often face economic constraints that limit the funding available for public health initiatives, including vaccination programs. Consequently, many poultry farmers and veterinary clinics are unable to afford the necessary vaccines and treatments, which in turn hinders effective disease control measures.
This financial barrier not only restricts the ability to implement widespread vaccination but also affects overall public health, as outbreaks of avian influenza can have devastating impacts on both animal populations and human health. Additionally, the high costs may lead to reliance on lower-quality or unproven treatments, which can exacerbate the situation by failing to effectively control the disease.
- Rising Emergence of New Strains
The ongoing emergence of new and Highly Pathogenic Avian Influenza (HPAI) strains presents significant challenges for vaccine development in Africa and Asia. These strains, which continuously evolve, can exhibit varying levels of virulence and resistance to existing vaccines. As a result, current vaccination strategies may not offer sufficient protection against these new variants, limiting their effectiveness in controlling outbreaks.
The rapid mutation of the virus strains demands a proactive approach to vaccine development, necessitating research and innovation to create vaccines that can effectively target these emerging pathogens. This situation creates complexities for both veterinary health officials and poultry farmers, as they must continuously adapt their strategies to mitigate the risks posed by these evolving strains. Additionally, the unpredictability of new strain outbreaks can lead to increased economic pressures on the poultry industry, which relies heavily on effective vaccination programs to maintain flock health and productivity.
Africa and Asia Avian Flu Market Scope
The market is segmented on the basis of strain, type, vaccine, vaccine category, application, end user, application, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Strain
- H5 Strain
- H7 Strain
- H9 Strain
Type
- Low Pathogenic Avian Influenza (LPAI)
- Highly Pathogenic Avian Influenza (HPAI)
Vaccine
- Gallimune/ Gallivac/ Volvac
- Nobilis influenza h5n2
- Mefluvac
- Viraflu
- Others
Vaccine Category
- Inactivated Vaccines
- Live Recombinant Vaccines
- Combination Vaccines
- DNA vaccine
Application
- Veterinary
- Chicken
- Duck and Goose
- Others
- Human
End User
- Poultry Farms
- Veterinary Clinics
- Governmental Organizations
- Research Institutes
- Others
Distribution Channel
- Direct Tenders
- Third Party Distributor
- Retail Sales
Africa and Asia Avian Flu Market Regional Analysis
The market is analyzed and market size insights and trends are provided by country strain, type, vaccine, vaccine category, application, end user, application, end user, and distribution channel as referenced above.
The countries covered in the market are China, Japan, India, Philippines, Indonesia, Bangladesh, Malaysia, Myanmar, Singapore, South Korea, Vietnam, Thailand, Cambodia, Nepal, North Korea, Uzbekistan, Pakistan, Srilanka, Kazakhstan, Tajikistan, Turkmenistan, Laos, Kyrgyzstan, Afghanistan, Mongolia, Timor-Leste, Maldives, Bhutan, Brunei Darussalam, Rest of Asia, Egypt, Nigeria, Kenya, Algeria, Ethiopia, Morocco, Ghana, Democratic Republic of Congo, Cameroon, Angola, Côte d'Ivoire, Libya, Rwanda, Burkina Faso, Mali, Benin, Namibia, Chad, Mauritius, Madagascar, Liberia, Congo (Rep), Guinea, Botswana, Eswatini, Niger, Malawi, Mozambique, Mauritania, Gabon, Eritrea, Gambia, Lesotho, Comoros, Burundi, Guinea-Bissau, Central African Republic, Cabo Verde, Djibouti, Equatorial Guinea, São Tomé and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, Togo, Tunisia, Uganda, Western Sahara, Zambia, Zimbabwe.
China is expected to dominate the market due to advancements in R&D technology and a presence of key players, and surge in R&D expenditure.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Africa and Asia Avian Flu Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Africa and Asia Avian Flu Market Leaders Operating in the Market Are:
- Boehringer Ingelheim International GmbH (Germany)
- Kemin Industries, Inc. (U.S.)
- Ceva (France)
- Merck & Co., Inc. (U.S.)
- China Animal Husbandry Group (China)
- Sinergium Biotech (Argentina)
- Qilu Animal Health Products Co., Ltd. (China)
Latest Developments in Africa and Asia Avian Flu Market
- In July 2024, Sinergium Biotech has been launched new initiative to accelerate the development of mRNA vaccines against avian influenza (H5N1) in low- and middle-income countries. Led by Sinergium Biotech, this project leverages the WHO and Medicines Patent Pool's mRNA Technology Transfer Programme. It aims to enhance manufacturing capacity and bolster pandemic preparedness by sharing technology and expertise with partners
- In January 2024, Ceva Santé Animal announced its acquisition of Scout Bio, a leader in pet biotechnology. This strategic move enhances Ceva's innovation capabilities, providing access to a pipeline of monoclonal antibodies and gene therapies for chronic pet diseases. The acquisition aims to accelerate biotherapeutic advancements while continuing Ceva's commitment to all species
- In October 2023, Sinergium Biotech Argentina and PAHO have signed a technical cooperation agreement to enhance RNA technology transfer for vaccine production. During a meeting with PAHO Director Jarbas Barbosa, Health Minister Carla Vizzotti emphasized the importance of this initiative for advancing vaccine development and reducing regional dependence on external technologies. The agreement aims to strengthen the mRNA ecosystem in Argentina, promoting equitable access to health solutions
- In April 2022, Ceva Santé Animale announced a joint venture with Mitsui, forming Ceva Bussan Animal Health K.K. in Japan. This partnership aims to enhance Ceva's presence in the Japanese market, focusing on food safety and disease control in livestock. Leaders from both companies expressed excitement about accelerating development and collaboration in addressing key industry challenges
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF AFRICA AND ASIA AVIAN FLU MARKET
1.4 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 AFRICA AND ASIA AVIAN FLU MARKET: REGULATIONS
5.1 REGULATORY AUTHORITIES IN AFRICA AND ASIA
5.2 REGULATORY SUBMISSIONS
5.3 INTERNATIONAL HARMONIZATION
5.4 REGULATORY CLASSIFICATIONS
5.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
5.6 REGULATORY CHALLENGES AND STRATEGIES
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING INCIDENCE OF AVIAN FLU OUTBREAKS
6.1.2 GROWTH OF POULTRY FARMING INDUSTRY
6.1.3 GOVERNMENT INITIATIVES AND VACCINATION PROGRAMS
6.2 RESTRAINTS
6.2.1 HIGH COST OF VACCINES AND TREATMENTS
6.2.2 VACCINE EFFICACY VARIABILITY
6.3 OPPORTUNITIES
6.3.1 RISING INVESTMENTS IN POULTRY INDUSTRY
6.3.2 EXPANSION OF VACCINE PORTFOLIOS
6.3.3 INCREASING STRATEGIC INITIATIVES
6.4 CHALLENGES
6.4.1 RISING EMERGENCE OF NEW STRAINS
6.4.2 RISING COMPETITION WITH ESTABLISHED PLAYERS
7 AFRICA AND ASIA AVIAN FLU MARKET, BY TYPE
7.1 OVERVIEW
7.2 LOW PATHOGENIC AVIAN INFLUENZA (LPAI)
7.3 HIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI)
8 AFRICA AND ASIA AVIAN FLU MARKET, BY VACCINE CATEGORY
8.1 OVERVIEW
8.2 INACTIVATED VACCINES
8.3 LIVE RECOMBINANT VACCINES
8.4 COMBINATION VACCINES
8.5 DNA VACCINE
9 AFRICA AND ASIA AVIAN FLU MARKET, BY VACCINE
9.1 OVERVIEW
9.2 NOBILIS INFLUENZA H5N2
9.3 GALLIMUNE/ GALLIVAC/ VOLVAC
9.4 MEFLUVAC
9.5 VIRAFLU
9.6 OTHERS
10 AFRICA AND ASIA AVIAN FLU MARKET, BY STRAIN
10.1 OVERVIEW
10.2 H5 STRAIN
10.3 H7 STRAIN
10.4 H9 STRAIN
11 AFRICA AND ASIA AVIAN FLU MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 VETERINARY
11.2.1 CHICKEN
11.2.2 DUCK AND GOOSE
11.2.3 OTHERS
11.3 HUMAN
12 AFRICA AND ASIA AVIAN FLU MARKET, BY END USER
12.1 OVERVIEW
12.2 POULTRY FARMS
12.3 VETERINARY CLINICS
12.4 RESEARCH INSTITUTES
12.5 GOVERNMENTAL ORGANIZATIONS
12.6 OTHERS
13 AFRICA AND ASIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 THIRD PARTY DISTRIBUTOR
13.4 RETAIL SALES
14 AFRICA AND ASIA AVIAN FLU MARKET, BY COUNTRY
14.1 ASIA
14.1.1 CHINA
14.1.2 JAPAN
14.1.3 INDIA
14.1.4 PHILIPPINES
14.1.5 INDONESIA
14.1.6 BANGLADESH
14.1.7 MALAYSIA
14.1.8 MYANMAR
14.1.9 SINNGAPORE
14.1.10 SOUTH KOREA
14.1.11 VIETNAM
14.1.12 THAILAND
14.1.13 CAMABODIA
14.1.14 NEPAL
14.1.15 NORTH KOREA
14.1.16 UZBEKISTAN
14.1.17 PAKISTAN
14.1.18 SRILANKA
14.1.19 KAZAKHSTAN
14.1.20 TAJIKISTAN
14.1.21 TURKMENISTAN
14.1.22 LAOS
14.1.23 KYRGYZSTAN
14.1.24 AFGHANISTAN
14.1.25 MONGOLIA
14.1.26 TIMOR LESTE
14.1.27 MALDIVES
14.1.28 BHUTAN
14.1.29 BRUNEI DARUSSALAM
14.1.30 REST OF ASIA
14.2 AFRICA
14.2.1 EGYPT
14.2.2 NIGERIA
14.2.3 KENYA
14.2.4 ALGERIA
14.2.5 ETHIOPIA
14.2.6 MOROCCO
14.2.7 GHANA
14.2.8 DEMOCRATIC REPUBLIC OF CONGO
14.2.9 CAMEROON
14.2.10 ANGOLA
14.2.11 COTE D’IVOIRE
14.2.12 LIBYA
14.2.13 RWANDA
14.2.14 BURKINA FASO
14.2.15 MALI
14.2.16 BENIN
14.2.17 NAMIBIA
14.2.18 CHAD
14.2.19 MAURITIUS
14.2.20 MADAGASCAR
14.2.21 LIBERIA
14.2.22 CONGO (REP)
14.2.23 GUINEA
14.2.24 BOTSWANA
14.2.25 ESWATINI
14.2.26 NIGER
14.2.27 MALAWI
14.2.28 MOZAMBIQUE
14.2.29 MAURITANIA
14.2.30 GABON
14.2.31 ERITREA
14.2.32 GAMBIA
14.2.33 LESOTHO
14.2.34 COMOROS
14.2.35 BURUNDI
14.2.36 GUINEA-BISSAU
14.2.37 CENTRAL AFRICAN REPUBLIC
14.2.38 CABO VERDE
14.2.39 DJIBOUTI
14.2.40 EQUATORIAL GUINEA
14.2.41 SÃO TOMÉ AND PRINCIPE
14.2.42 SENEGAL
14.2.43 SEYCHELLES
14.2.44 SIERRA LEONE
14.2.45 SOMALIA
14.2.46 SOUTH AFRICA
14.2.47 SOUTH SUDAN
14.2.48 SUDAN
14.2.49 TANZANIA
14.2.50 TOGO
14.2.51 TUNISIA
14.2.52 UGANDA
14.2.53 WESTERN SAHARA
14.2.54 ZAMBIA
14.2.55 ZIMBABWE
14.2.56 REST OF AFRICA
15 AFRICA AND ASIA AVIAN FLU MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA
15.2 COMPANY SHARE ANALYSIS: AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILES
17.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
17.1.1 COMPANY SNAPSHOT
17.1.2 PRODUCT PORTFOLIO
17.1.3 RECENT DEVELOPMENT
17.2 MERCK & CO., INC.,
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENTS
17.3 KEMIN INDUSTRIES, INC.
17.3.1 COMPANY SNAPSHOT
17.3.2 PRODUCT PORTFOLIO
17.3.3 RECENT DEVELOPMENT
17.4 CEVA
17.4.1 COMPANY SNAPSHOT
17.4.2 PRODUCT PORTFOLIO
17.4.3 RECENT DEVELOPMENT
17.5 CHINA ANIMAL HUSBANDRY GROUP
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVELOPMENT
17.6 QILU ANIMAL HEALTH PRODUCTS CO., LTD.
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 SINERGIUM BIOTECH
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
TABLE 1 AFRICA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 2 ASIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 3 AFRICA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 4 ASIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 5 AFRICA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 6 ASIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 7 AFRICA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 8 ASIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 9 AFRICA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 10 ASIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 11 AFRICA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 12 ASIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 13 AFRICA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 ASIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 15 AFRICA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 16 ASIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 17 AFRICA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 18 ASIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 19 ASIA AVIAN FLU MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 20 ASIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 21 ASIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 22 ASIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 23 ASIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 24 ASIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 25 ASIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 26 ASIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 27 ASIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 28 ASIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 29 ASIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 30 CHINA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 31 CHINA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 32 CHINA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 33 CHINA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 34 CHINA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 35 CHINA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 36 CHINA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 37 CHINA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 38 CHINA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 39 CHINA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 40 JAPAN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 41 JAPAN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 42 JAPAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 43 JAPAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 44 JAPAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 45 JAPAN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 46 JAPAN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 47 JAPAN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 48 JAPAN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 49 JAPAN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 50 INDIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 51 INDIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 52 INDIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 53 INDIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 54 INDIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 55 INDIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 56 INDIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 57 INDIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 58 INDIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 59 INDIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 60 PHILIPPINES AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 61 PHILIPPINES AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 PHILIPPINES AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 63 PHILIPPINES AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 64 PHILIPPINES AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 65 PHILIPPINES AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 66 PHILIPPINES AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 67 PHILIPPINES VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 68 PHILIPPINES AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 69 PHILIPPINES AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 70 INDONESIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 71 INDONESIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 72 INDONESIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 73 INDONESIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 74 INDONESIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 75 INDONESIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 76 INDONESIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 77 INDONESIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 78 INDONESIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 79 INDONESIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 80 BANGLADESH AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 81 BANGLADESH AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 82 BANGLADESH AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 83 BANGLADESH AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 84 BANGLADESH AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 85 BANGLADESH AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 86 BANGLADESH AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 87 BANGLADESH VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 88 BANGLADESH AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 89 BANGLADESH AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 90 MALAYSIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 91 MALAYSIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 92 MALAYSIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 93 MALAYSIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 94 MALAYSIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 95 MALAYSIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 96 MALAYSIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 97 MALAYSIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 98 MALAYSIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 99 MALAYSIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 100 MYANMAR AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 101 MYANMAR AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 102 MYANMAR AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 103 MYANMAR AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 104 MYANMAR AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 105 MYANMAR AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 106 MYANMAR AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 107 MYANMAR VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 108 MYANMAR AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 109 MYANMAR AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 110 SINGAPORE AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 111 SINGAPORE AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 112 SINGAPORE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 113 SINGAPORE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 114 SINGAPORE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 115 SINGAPORE AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 116 SINGAPORE AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 117 SINGAPORE VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 118 SINGAPORE AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 119 SINGAPORE AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 120 SOUTH KOREA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 121 SOUTH KOREA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 SOUTH KOREA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 123 SOUTH KOREA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 124 SOUTH KOREA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 125 SOUTH KOREA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 126 SOUTH KOREA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 127 SOUTH KOREA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 128 SOUTH KOREA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 129 SOUTH KOREA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 130 VIETNAM AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 131 VIETNAM AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 VIETNAM AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 133 VIETNAM AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 134 VIETNAM AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 135 VIETNAM AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 136 VIETNAM AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 137 VIETNAM VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 138 VIETNAM AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 139 VIETNAM AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 140 THAILAND AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 141 THAILAND AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 142 THAILAND AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 143 THAILAND AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 144 THAILAND AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 145 THAILAND AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 146 THAILAND AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 147 THAILAND VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 148 THAILAND AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 149 THAILAND AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 150 CAMBODIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 151 CAMBODIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 152 CAMBODIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 153 CAMBODIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 154 CAMBODIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 155 CAMBODIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 156 CAMBODIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 157 CAMBODIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 158 CAMBODIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 159 CAMBODIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 160 NEPAL AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 161 NEPAL AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 162 NEPAL AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 163 NEPAL AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 164 NEPAL AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 165 NEPAL AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 166 NEPAL AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 167 NEPAL VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 NEPAL AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 169 NEPAL AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 170 NORTH KOREA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 171 NORTH KOREA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 172 NORTH KOREA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 173 NORTH KOREA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 174 NORTH KOREA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 175 NORTH KOREA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 176 NORTH KOREA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 177 NORTH KOREA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 178 NORTH KOREA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 179 NORTH KOREA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 180 UZBEKISTAN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 181 UZBEKISTAN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 182 UZBEKISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 183 UZBEKISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 184 UZBEKISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 185 UZBEKISTAN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 186 UZBEKISTAN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 187 UZBEKISTAN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 188 UZBEKISTAN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 189 UZBEKISTAN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 190 PAKISTAN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 191 PAKISTAN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 192 PAKISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 193 PAKISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 194 PAKISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 195 PAKISTAN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 196 PAKISTAN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 197 PAKISTAN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 198 PAKISTAN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 199 PAKISTAN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 200 SRILANKA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 201 SRILANKA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 202 SRILANKA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 203 SRILANKA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 204 SRILANKA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 205 SRILANKA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 206 SRILANKA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 207 SRILANKA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 208 SRILANKA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 209 SRILANKA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 210 KAZAKHSTAN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 211 KAZAKHSTAN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 212 KAZAKHSTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 213 KAZAKHSTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 214 KAZAKHSTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 215 KAZAKHSTAN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 216 KAZAKHSTAN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 217 KAZAKHSTAN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 218 KAZAKHSTAN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 219 KAZAKHSTAN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 220 TAJIKISTAN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 221 TAJIKISTAN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 222 TAJIKISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 223 TAJIKISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 224 TAJIKISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 225 TAJIKISTAN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 226 TAJIKISTAN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 227 TAJIKISTAN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 228 TAJIKISTAN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 229 TAJIKISTAN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 230 TURKMENISTAN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 231 TURKMENISTAN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 232 TURKMENISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 233 TURKMENISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 234 TURKMENISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 235 TURKMENISTAN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 236 TURKMENISTAN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 237 TURKMENISTAN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 238 TURKMENISTAN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 239 TURKMENISTAN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 240 LAOS AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 241 LAOS AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 242 LAOS AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 243 LAOS AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 244 LAOS AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 245 LAOS AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 246 LAOS AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 247 LAOS VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 248 LAOS AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 249 LAOS AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 250 KYRGYZSTAN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 251 KYRGYZSTAN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 252 KYRGYZSTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 253 KYRGYZSTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 254 KYRGYZSTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 255 KYRGYZSTAN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 256 KYRGYZSTAN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 257 KYRGYZSTAN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 258 KYRGYZSTAN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 259 KYRGYZSTAN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 260 AFGHANISTAN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 261 AFGHANISTAN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 262 AFGHANISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 263 AFGHANISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 264 AFGHANISTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 265 AFGHANISTAN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 266 AFGHANISTAN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 267 AFGHANISTAN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 268 AFGHANISTAN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 269 AFGHANISTAN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 270 MONGOLIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 271 MONGOLIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 272 MONGOLIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 273 MONGOLIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 274 MONGOLIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 275 MONGOLIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 276 MONGOLIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 277 MONGOLIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 278 MONGOLIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 279 MONGOLIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 280 TIMOR-LESTE AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 281 TIMOR-LESTE AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 282 TIMOR-LESTE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 283 TIMOR-LESTE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 284 TIMOR-LESTE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 285 TIMOR-LESTE AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 286 TIMOR-LESTE AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 287 TIMOR-LESTE VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 288 TIMOR-LESTE AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 289 TIMOR-LESTE AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 290 MALDIVES AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 291 MALDIVES AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 292 MALDIVES AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 293 MALDIVES AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 294 MALDIVES AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 295 MALDIVES AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 296 MALDIVES AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 297 MALDIVES VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 298 MALDIVES AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 299 MALDIVES AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 300 BHUTAN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 301 BHUTAN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 302 BHUTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 303 BHUTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 304 BHUTAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 305 BHUTAN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 306 BHUTAN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 307 BHUTAN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 308 BHUTAN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 309 BHUTAN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 310 BRUNEI DARUSSALAM AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 311 BRUNEI DARUSSALAM AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 312 BRUNEI DARUSSALAM AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 313 BRUNEI DARUSSALAM AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 314 BRUNEI DARUSSALAM AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 315 BRUNEI DARUSSALAM AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 316 BRUNEI DARUSSALAM AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 317 BRUNEI DARUSSALAM VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 318 BRUNEI DARUSSALAM AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 319 BRUNEI DARUSSALAM AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 320 REST OF ASIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 321 AFRICA AVIAN FLU MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 322 AFRICA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 323 AFRICA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 324 AFRICA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 325 AFRICA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 326 AFRICA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 327 AFRICA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 328 AFRICA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 329 AFRICA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 330 AFRICA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 331 AFRICA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 332 EGYPT AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 333 EGYPT AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 334 EGYPT AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 335 EGYPT AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 336 EGYPT AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 337 EGYPT AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 338 EGYPT AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 339 EGYPT VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 340 EGYPT AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 341 EGYPT AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 342 NIGERIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 343 NIGERIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 344 NIGERIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 345 NIGERIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 346 NIGERIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 347 NIGERIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 348 NIGERIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 349 NIGERIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 350 NIGERIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 351 NIGERIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 352 KENYA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 353 KENYA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 354 KENYA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 355 KENYA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 356 KENYA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 357 KENYA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 358 KENYA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 359 KENYA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 360 KENYA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 361 KENYA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 362 ALGERIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 363 ALGERIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 364 ALGERIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 365 ALGERIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 366 ALGERIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 367 ALGERIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 368 ALGERIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 369 ALGERIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 370 ALGERIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 371 ALGERIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 372 ETHIOPIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 373 ETHIOPIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 374 ETHIOPIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 375 ETHIOPIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 376 ETHIOPIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 377 ETHIOPIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 378 ETHIOPIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 379 ETHIOPIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 380 ETHIOPIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 381 ETHIOPIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 382 MOROCCO AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 383 MOROCCO AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 384 MOROCCO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 385 MOROCCO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 386 MOROCCO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 387 MOROCCO AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 388 MOROCCO AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 389 MOROCCO VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 390 MOROCCO AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 391 MOROCCO AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 392 GHANA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 393 GHANA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 394 GHANA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 395 GHANA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 396 GHANA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 397 GHANA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 398 GHANA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 399 GHANA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 400 GHANA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 401 GHANA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 402 DEMOCRATIC REPUBLIC OF CONGO AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 403 DEMOCRATIC REPUBLIC OF CONGO AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 404 DEMOCRATIC REPUBLIC OF CONGO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 405 DEMOCRATIC REPUBLIC OF CONGO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 406 DEMOCRATIC REPUBLIC OF CONGO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 407 DEMOCRATIC REPUBLIC OF CONGO AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 408 DEMOCRATIC REPUBLIC OF CONGO AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 409 DEMOCRATIC REPUBLIC OF CONGO VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 410 DEMOCRATIC REPUBLIC OF CONGO AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 411 DEMOCRATIC REPUBLIC OF CONGO AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 412 CAMEROON AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 413 CAMEROON AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 414 CAMEROON AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 415 CAMEROON AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 416 CAMEROON AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 417 CAMEROON AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 418 CAMEROON AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 419 CAMEROON VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 420 CAMEROON AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 421 CAMEROON AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 422 ANGOLA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 423 ANGOLA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 424 ANGOLA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 425 ANGOLA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 426 ANGOLA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 427 ANGOLA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 428 ANGOLA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 429 ANGOLA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 430 ANGOLA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 431 ANGOLA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 432 COTE D'IVOIRE AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 433 COTE D'IVOIRE AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 434 COTE D'IVOIRE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 435 COTE D'IVOIRE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 436 COTE D'IVOIRE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 437 COTE D'IVOIRE AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 438 COTE D'IVOIRE AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 439 COTE D'IVOIRE VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 440 COTE D'IVOIRE AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 441 COTE D'IVOIRE AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 442 LIBYA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 443 LIBYA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 444 LIBYA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 445 LIBYA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 446 LIBYA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 447 LIBYA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 448 LIBYA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 449 LIBYA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 450 LIBYA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 451 LIBYA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 452 RWANDA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 453 RWANDA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 454 RWANDA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 455 RWANDA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 456 RWANDA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 457 RWANDA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 458 RWANDA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 459 RWANDA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 460 RWANDA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 461 RWANDA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 462 BURKINA FASO AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 463 BURKINA FASO AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 464 BURKINA FASO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 465 BURKINA FASO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 466 BURKINA FASO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 467 BURKINA FASO AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 468 BURKINA FASO AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 469 BURKINA FASO VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 470 BURKINA FASO AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 471 BURKINA FASO AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 472 MALI AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 473 MALI AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 474 MALI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 475 MALI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 476 MALI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 477 MALI AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 478 MALI AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 479 MALI VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 480 MALI AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 481 MALI AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 482 BENIN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 483 BENIN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 484 BENIN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 485 BENIN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 486 BENIN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 487 BENIN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 488 BENIN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 489 BENIN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 490 BENIN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 491 BENIN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 492 NAMIBIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 493 NAMIBIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 494 NAMIBIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 495 NAMIBIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 496 NAMIBIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 497 NAMIBIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 498 NAMIBIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 499 NAMIBIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 500 NAMIBIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 501 NAMIBIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 502 CHAD AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 503 CHAD AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 504 CHAD AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 505 CHAD AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 506 CHAD AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 507 CHAD AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 508 CHAD AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 509 CHAD VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 510 CHAD AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 511 CHAD AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 512 MAURITIUS AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 513 MAURITIUS AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 514 MAURITIUS AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 515 MAURITIUS AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 516 MAURITIUS AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 517 MAURITIUS AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 518 MAURITIUS AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 519 MAURITIUS VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 520 MAURITIUS AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 521 MAURITIUS AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 522 MADAGASCAR AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 523 MADAGASCAR AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 524 MADAGASCAR AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 525 MADAGASCAR AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 526 MADAGASCAR AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 527 MADAGASCAR AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 528 MADAGASCAR AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 529 MADAGASCAR VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 530 MADAGASCAR AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 531 MADAGASCAR AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 532 LIBERIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 533 LIBERIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 534 LIBERIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 535 LIBERIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 536 LIBERIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 537 LIBERIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 538 LIBERIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 539 LIBERIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 540 LIBERIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 541 LIBERIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 542 CONGO (REP) AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 543 CONGO (REP) AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 544 CONGO (REP) AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 545 CONGO (REP) AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 546 CONGO (REP) AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 547 CONGO (REP) AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 548 CONGO (REP) AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 549 CONGO (REP) VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 550 CONGO (REP) AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 551 CONGO (REP) AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 552 GUINEA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 553 GUINEA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 554 GUINEA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 555 GUINEA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 556 GUINEA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 557 GUINEA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 558 GUINEA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 559 GUINEA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 560 GUINEA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 561 GUINEA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 562 BOTSWANA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 563 BOTSWANA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 564 BOTSWANA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 565 BOTSWANA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 566 BOTSWANA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 567 BOTSWANA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 568 BOTSWANA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 569 BOTSWANA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 570 BOTSWANA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 571 BOTSWANA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 572 ESWATINI AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 573 ESWATINI AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 574 ESWATINI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 575 ESWATINI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 576 ESWATINI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 577 ESWATINI AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 578 ESWATINI AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 579 ESWATINI VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 580 ESWATINI AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 581 ESWATINI AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 582 NIGER AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 583 NIGER AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 584 NIGER AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 585 NIGER AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 586 NIGER AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 587 NIGER AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 588 NIGER AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 589 NIGER VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 590 NIGER AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 591 NIGER AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 592 MALAWI AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 593 MALAWI AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 594 MALAWI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 595 MALAWI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 596 MALAWI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 597 MALAWI AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 598 MALAWI AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 599 MALAWI VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 600 MALAWI AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 601 MALAWI AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 602 MOZAMBIQUE AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 603 MOZAMBIQUE AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 604 MOZAMBIQUE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 605 MOZAMBIQUE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 606 MOZAMBIQUE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 607 MOZAMBIQUE AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 608 MOZAMBIQUE AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 609 MOZAMBIQUE VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 610 MOZAMBIQUE AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 611 MOZAMBIQUE AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 612 MAURITANIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 613 MAURITANIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 614 MAURITANIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 615 MAURITANIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 616 MAURITANIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 617 MAURITANIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 618 MAURITANIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 619 MAURITANIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 620 MAURITANIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 621 MAURITANIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 622 GABON AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 623 GABON AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 624 GABON AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 625 GABON AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 626 GABON AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 627 GABON AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 628 GABON AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 629 GABON VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 630 GABON AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 631 GABON AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 632 ERITREA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 633 ERITREA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 634 ERITREA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 635 ERITREA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 636 ERITREA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 637 ERITREA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 638 ERITREA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 639 ERITREA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 640 ERITREA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 641 ERITREA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 642 GAMBIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 643 GAMBIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 644 GAMBIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 645 GAMBIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 646 GAMBIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 647 GAMBIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 648 GAMBIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 649 GAMBIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 650 GAMBIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 651 GAMBIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 652 LESOTHO AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 653 LESOTHO AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 654 LESOTHO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 655 LESOTHO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 656 LESOTHO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 657 LESOTHO AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 658 LESOTHO AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 659 LESOTHO VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 660 LESOTHO AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 661 LESOTHO AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 662 COMOROS AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 663 COMOROS AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 664 COMOROS AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 665 COMOROS AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 666 COMOROS AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 667 COMOROS AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 668 COMOROS AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 669 COMOROS VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 670 COMOROS AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 671 COMOROS AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 672 BURUNDI AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 673 BURUNDI AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 674 BURUNDI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 675 BURUNDI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 676 BURUNDI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 677 BURUNDI AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 678 BURUNDI AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 679 BURUNDI VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 680 BURUNDI AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 681 BURUNDI AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 682 GUINEA-BISSAU AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 683 GUINEA-BISSAU AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 684 GUINEA-BISSAU AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 685 GUINEA-BISSAU AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 686 GUINEA-BISSAU AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 687 GUINEA-BISSAU AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 688 GUINEA-BISSAU AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 689 GUINEA-BISSAU VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 690 GUINEA-BISSAU AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 691 GUINEA-BISSAU AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 692 CENTRAL AFRICAN REPUBLIC AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 693 CENTRAL AFRICAN REPUBLIC AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 694 CENTRAL AFRICAN REPUBLIC AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 695 CENTRAL AFRICAN REPUBLIC AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 696 CENTRAL AFRICAN REPUBLIC AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 697 CENTRAL AFRICAN REPUBLIC AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 698 CENTRAL AFRICAN REPUBLIC AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 699 CENTRAL AFRICAN REPUBLIC VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 700 CENTRAL AFRICAN REPUBLIC AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 701 CENTRAL AFRICAN REPUBLIC AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 702 CABO VERDE AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 703 CABO VERDE AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 704 CABO VERDE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 705 CABO VERDE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 706 CABO VERDE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 707 CABO VERDE AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 708 CABO VERDE AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 709 CABO VERDE VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 710 CABO VERDE AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 711 CABO VERDE AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 712 DJIBOUTI AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 713 DJIBOUTI AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 714 DJIBOUTI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 715 DJIBOUTI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 716 DJIBOUTI AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 717 DJIBOUTI AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 718 DJIBOUTI AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 719 DJIBOUTI VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 720 DJIBOUTI AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 721 DJIBOUTI AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 722 EQUATORIAL GUINEA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 723 EQUATORIAL GUINEA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 724 EQUATORIAL GUINEA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 725 EQUATORIAL GUINEA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 726 EQUATORIAL GUINEA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 727 EQUATORIAL GUINEA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 728 EQUATORIAL GUINEA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 729 EQUATORIAL GUINEA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 730 EQUATORIAL GUINEA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 731 EQUATORIAL GUINEA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 732 SÃO TOMÉ AND PRINCIPE AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 733 SÃO TOMÉ AND PRINCIPE AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 734 SÃO TOMÉ AND PRINCIPE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 735 SÃO TOMÉ AND PRINCIPE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 736 SÃO TOMÉ AND PRINCIPE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 737 SÃO TOMÉ AND PRINCIPE AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 738 SÃO TOMÉ AND PRINCIPE AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 739 SÃO TOMÉ AND PRINCIPE VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 740 SÃO TOMÉ AND PRINCIPE AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 741 SÃO TOMÉ AND PRINCIPE AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 742 SENEGAL AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 743 SENEGAL AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 744 SENEGAL AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 745 SENEGAL AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 746 SENEGAL AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 747 SENEGAL AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 748 SENEGAL AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 749 SENEGAL AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 750 SENEGAL AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 751 SEYCHELLES AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 752 SEYCHELLES AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 753 SEYCHELLES AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 754 SEYCHELLES AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 755 SEYCHELLES AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 756 SEYCHELLES AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 757 SEYCHELLES AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 758 SEYCHELLES VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 759 SEYCHELLES AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 760 SEYCHELLES AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 761 SIERRA LEONE AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 762 SIERRA LEONE AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 763 SIERRA LEONE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 764 SIERRA LEONE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 765 SIERRA LEONE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 766 SIERRA LEONE AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 767 SIERRA LEONE AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 768 SIERRA LEONE VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 769 SIERRA LEONE AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 770 SIERRA LEONE AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 771 SOMALIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 772 SOMALIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 773 SOMALIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 774 SOMALIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 775 SOMALIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 776 SOMALIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 777 SOMALIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 778 SOMALIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 779 SOMALIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 780 SOMALIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 781 SOUTH AFRICA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 782 SOUTH AFRICA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 783 SOUTH AFRICA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 784 SOUTH AFRICA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 785 SOUTH AFRICA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 786 SOUTH AFRICA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 787 SOUTH AFRICA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 788 SOUTH AFRICA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 789 SOUTH AFRICA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 790 SOUTH AFRICA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 791 SOUTH SUDAN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 792 SOUTH SUDAN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 793 SOUTH SUDAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 794 SOUTH SUDAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 795 SOUTH SUDAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 796 SOUTH SUDAN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 797 SOUTH SUDAN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 798 SOUTH SUDAN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 799 SOUTH SUDAN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 800 SOUTH SUDAN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 801 SUDAN AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 802 SUDAN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 803 SUDAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 804 SUDAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 805 SUDAN AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 806 SUDAN AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 807 SUDAN AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 808 SUDAN VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 809 SUDAN AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 810 SUDAN AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 811 TANZANIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 812 TANZANIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 813 TANZANIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 814 TANZANIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 815 TANZANIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 816 TANZANIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 817 TANZANIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 818 TANZANIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 819 TANZANIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 820 TANZANIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 821 TOGO AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 822 TOGO AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 823 TOGO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 824 TOGO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 825 TOGO AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 826 TOGO AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 827 TOGO AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 828 TOGO VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 829 TOGO AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 830 TOGO AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 831 TUNISIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 832 TUNISIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 833 TUNISIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 834 TUNISIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 835 TUNISIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 836 TUNISIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 837 TUNISIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 838 TUNISIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 839 TUNISIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 840 TUNISIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 841 UGANDA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 842 UGANDA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 843 UGANDA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 844 UGANDA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 845 UGANDA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 846 UGANDA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 847 UGANDA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 848 UGANDA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 849 UGANDA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 850 UGANDA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 851 WESTERN SAHARA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 852 WESTERN SAHARA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 853 WESTERN SAHARA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 854 WESTERN SAHARA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 855 WESTERN SAHARA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 856 WESTERN SAHARA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 857 WESTERN SAHARA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 858 WESTERN SAHARA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 859 WESTERN SAHARA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 860 WESTERN SAHARA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 861 ZAMBIA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 862 ZAMBIA AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 863 ZAMBIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 864 ZAMBIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 865 ZAMBIA AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 866 ZAMBIA AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 867 ZAMBIA AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 868 ZAMBIA VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 869 ZAMBIA AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 870 ZAMBIA AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 871 ZIMBABWE AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
TABLE 872 ZIMBABWE AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 873 ZIMBABWE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (USD THOUSAND)
TABLE 874 ZIMBABWE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (VOLUME)
TABLE 875 ZIMBABWE AVIAN FLU MARKET, BY VACCINE, 2022-2031 (ASP)
TABLE 876 ZIMBABWE AVIAN FLU MARKET, BY VACCINE CATEGORY, 2022-2031 (USD THOUSAND)
TABLE 877 ZIMBABWE AVIAN FLU MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 878 ZIMBABWE VETERINARY IN AVIAN FLU MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 879 ZIMBABWE AVIAN FLU MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 880 ZIMBABWE AVIAN FLU MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 881 REST OF AFRICA AVIAN FLU MARKET, BY STRAIN, 2022-2031 (USD THOUSAND)
그림 목록
FIGURE 1 AFRICA AND ASIA AVIAN FLU MARKET: SEGMENTATION
FIGURE 2 AFRICA AND ASIA AVIAN FLU MARKET: DATA TRIANGULATION
FIGURE 3 AFRICA AND ASIA AVIAN FLU MARKET: DROC ANALYSIS
FIGURE 4 AFRICA AVIAN FLU MARKET: COUNTRY-WISE MARKET ANALYSIS
FIGURE 5 ASIA AVIAN FLU MARKET: COUNTRY-WISE MARKET ANALYSIS
FIGURE 6 AFRICA AND ASIA AVIAN FLU MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 7 AFRICA AND ASIA AVIAN FLU MARKET: MULTIVARIATE MODELLING
FIGURE 8 AFRICA AND ASIA AVIAN FLU MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 ASIA AVIAN FLU MARKET: DBMR MARKET POSITION GRID
FIGURE 10 AFRICA AVIAN FLU MARKET: DBMR MARKET POSITION GRID
FIGURE 11 ASIA AVIAN FLU MARKET: MARKET END USER COVERAGE GRID
FIGURE 12 AFRICA AVIAN FLU MARKET: MARKET END USER COVERAGE GRID
FIGURE 13 AFRICA AND ASIA AVIAN FLU MARKET: SEGMENTATION
FIGURE 14 THREE SEGMENTS COMPRISE THE AFRICA AVIAN FLU MARKET, BY STRAIN
FIGURE 15 THREE SEGMENTS COMPRISE THE ASIA AVIAN FLU MARKET, BY STRAIN TYPE
FIGURE 16 AFRICA AND ASIA AVIAN FLU MARKET: EXECUTIVE SUMMARY
FIGURE 17 AFRICA AND ASIA AVIAN FLU MARKET: EXECUTIVE SUMMARY
FIGURE 18 STRATEGIC DECISIONS
FIGURE 19 RISING INCIDENCE OF AVIAN FLU OUTBREAKS IS DRIVING THE ASIA AVIAN FLU MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 20 H5 STRAIN SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA FLU MARKET IN 2024 & 2031
FIGURE 21 RISING INCIDENCE OF AVIAN FLU OUTBREAKS IS DRIVING THE AFRICA AVIAN FLU MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 22 H5 STRAIN SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE AFRICA FLU MARKET IN 2024 & 2031
FIGURE 23 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR AFRICA AND ASIA AVIAN FLU MARKET
FIGURE 24 AFRICA AVIAN FLU MARKET: BY TYPE, 2023
FIGURE 25 AFRICA AVIAN FLU MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 26 AFRICA AVIAN FLU MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 27 AFRICA AVIAN FLU MARKET: BY TYPE, LIFELINE CURVE
FIGURE 28 ASIA AVIAN FLU MARKET: BY TYPE, 2023
FIGURE 29 ASIA AVIAN FLU MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 30 ASIA AVIAN FLU MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 31 ASIA AVIAN FLU MARKET: BY TYPE, LIFELINE CURVE
FIGURE 32 AFRICA AVIAN FLU MARKET: BY VACCINE CATEGORY, 2023
FIGURE 33 AFRICA AVIAN FLU MARKET: BY VACCINE CATEGORY, 2024-2031 (USD THOUSAND)
FIGURE 34 AFRICA AVIAN FLU MARKET: BY VACCINE CATEGORY, CAGR (2024-2031)
FIGURE 35 AFRICA AVIAN FLU MARKET: BY VACCINE CATEGORY, LIFELINE CURVE
FIGURE 36 ASIA AVIAN FLU MARKET: BY VACCINE CATEGORY, 2023
FIGURE 37 ASIA AVIAN FLU MARKET: BY VACCINE CATEGORY, 2024-2031 (USD THOUSAND)
FIGURE 38 ASIA AVIAN FLU MARKET: BY VACCINE CATEGORY, CAGR (2024-2031)
FIGURE 39 ASIA AVIAN FLU MARKET: BY VACCINE CATEGORY, LIFELINE CURVE
FIGURE 40 AFRICA AVIAN FLU MARKET: BY VACCINE, 2023
FIGURE 41 AFRICA AVIAN FLU MARKET: BY VACCINE, 2024-2031 (USD THOUSAND)
FIGURE 42 AFRICA AVIAN FLU MARKET: BY VACCINE, CAGR (2024-2031)
FIGURE 43 AFRICA AVIAN FLU MARKET: BY VACCINE, LIFELINE CURVE
FIGURE 44 ASIA AVIAN FLU MARKET: BY VACCINE, 2023
FIGURE 45 ASIA AVIAN FLU MARKET: BY VACCINE, 2024-2031 (USD THOUSAND)
FIGURE 46 ASIA AVIAN FLU MARKET: BY VACCINE, CAGR (2024-2031)
FIGURE 47 ASIA AVIAN FLU MARKET: BY VACCINE, LIFELINE CURVE
FIGURE 48 AFRICA AVIAN FLU MARKET: BY STRAIN, 2023
FIGURE 49 AFRICA AVIAN FLU MARKET: BY STRAIN, 2024-2031 (USD THOUSAND)
FIGURE 50 AFRICA AVIAN FLU MARKET: BY STRAIN, CAGR (2024-2031)
FIGURE 51 AFRICA AVIAN FLU MARKET: BY STRAIN, LIFELINE CURVE
FIGURE 52 ASIA AVIAN FLU MARKET: BY STRAIN, 2023
FIGURE 53 ASIA AVIAN FLU MARKET: BY STRAIN, 2024-2031 (USD THOUSAND)
FIGURE 54 ASIA AVIAN FLU MARKET: BY STRAIN, CAGR (2024-2031)
FIGURE 55 ASIA AVIAN FLU MARKET: BY STRAIN, LIFELINE CURVE
FIGURE 56 AFRICA AVIAN FLU MARKET: BY APPLICATION, 2023
FIGURE 57 AFRICA AVIAN FLU MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 58 AFRICA AVIAN FLU MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 59 AFRICA AVIAN FLU MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 60 ASIA AVIAN FLU MARKET: BY APPLICATION, 2023
FIGURE 61 ASIA AVIAN FLU MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 62 ASIA AVIAN FLU MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 63 ASIA AVIAN FLU MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 64 AFRICA AVIAN FLU MARKET: BY END USER, 2023
FIGURE 65 AFRICA AVIAN FLU MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 66 AFRICA AVIAN FLU MARKET: BY END USER, CAGR (2024-2031)
FIGURE 67 AFRICA AVIAN FLU MARKET: BY END USER, LIFELINE CURVE
FIGURE 68 ASIA AVIAN FLU MARKET: BY END USER, 2023
FIGURE 69 ASIA AVIAN FLU MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 70 ASIA AVIAN FLU MARKET: BY END USER, CAGR (2024-2031)
FIGURE 71 ASIA AVIAN FLU MARKET: BY END USER, LIFELINE CURVE
FIGURE 72 AFRICA AVIAN FLU MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 73 AFRICA AVIAN FLU MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 74 AFRICA AVIAN FLU MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 75 AFRICA AVIAN FLU MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 76 ASIA AVIAN FLU MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 77 ASIA AVIAN FLU MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 78 ASIA AVIAN FLU MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 79 ASIA AVIAN FLU MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 80 ASIA AVIAN FLU MARKET SNAPSHOT
FIGURE 81 AFRICA AVIAN FLU MARKET SNAPSHOT
FIGURE 82 ASIA AVIAN FLU MARKET: COMPANY SHARE 2023 (%)
FIGURE 83 AFRICA AVIAN FLU MARKET: COMPANY SHARE 2023 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
